{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T23:23:18Z","timestamp":1778282598818,"version":"3.51.4"},"reference-count":17,"publisher":"Japan Society for Clinical Immunology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2177\/jsci.36.197","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T23:14:01Z","timestamp":1377904441000},"page":"197-202","source":"Crossref","is-referenced-by-count":5,"title":["Syk inhibitors","\u30c1\u30ed\u30b7\u30f3\u30ad\u30ca\u30fc\u30bcSyk\u306e\u751f\u7406\u6a5f\u80fd\u3068\u305d\u306e\u963b\u5bb3\u85ac"],"prefix":"10.2177","volume":"36","author":[{"given":"Kazuyasu","family":"CHIHARA","sequence":"first","affiliation":[{"name":"Division of Genome Science and Microbiology, Faculty of Medical Sciences, University of Fukui"},{"name":"Organization for Life Science Advancement Programs, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"KIMURA","sequence":"additional","affiliation":[{"name":"Division of Genome Science and Microbiology, Faculty of Medical Sciences, University of Fukui"},{"name":"Division of Otorhinolaryngology Head and Neck Surgery, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chisato","family":"HONJO","sequence":"additional","affiliation":[{"name":"Division of Genome Science and Microbiology, Faculty of Medical Sciences, University of Fukui"},{"name":"Division of Respiratory Medicine, Faculty of Medical Sciences, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"TAKEUCHI","sequence":"additional","affiliation":[{"name":"Division of Genome Science and Microbiology, Faculty of Medical Sciences, University of Fukui"},{"name":"Organization for Life Science Advancement Programs, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyonao","family":"SADA","sequence":"additional","affiliation":[{"name":"Division of Genome Science and Microbiology, Faculty of Medical Sciences, University of Fukui"},{"name":"Organization for Life Science Advancement Programs, University of Fukui"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Sakai, K., et al. : Characterization of partially purified cytosolic protein-tyrosine kinase from porcine spleen. Biochem. Biophys. Res. Commun<\/i>. 152<\/b> : 1123-1130, 1988."},{"key":"2","unstructured":"2) Taniguchi, T., et al. : Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J. Biol. Chem<\/i>. 266<\/b> : 15790-15796, 1991."},{"key":"3","unstructured":"3) Sada, K., et al. : Structure and function of Syk protein-tyrosine kinase. J. Biochem<\/i>. 130<\/b> : 177-186, 2001."},{"key":"4","unstructured":"4) Mocsai, A., et al. : The Syk tyrosine kinase : a crucial player in diverse biological functions. Nat. Rev. Immunol<\/i>. 10<\/b> : 387-402, 2010."},{"key":"5","unstructured":"5) Coopman, P.J., et al. : The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature<\/i> 406<\/b> : 742-747, 2000."},{"key":"6","unstructured":"6) Bailet, O., et al. : Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest. Cancer Res<\/i>. 69<\/b> : 2748-2756, 2009."},{"key":"7","unstructured":"7) Hahn, C.K., et al. : Proteomic and genetic approaches identify Syk as an AML target. Cancer Cell<\/i> 16<\/b> : 281-294, 2009."},{"key":"8","unstructured":"8) Zhang, J., et al. : A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature<\/i> 481<\/b> : 329-334, 2012."},{"key":"9"},{"key":"10","unstructured":"10) Weinblatt, M.E., et al. : An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis. N. Engl. J. Med<\/i>. 363<\/b> : 1303-1312, 2010."},{"key":"11","unstructured":"11) Coffey, G., et al. : Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis. J. Pharmacol. Exp. Ther<\/i>. 340<\/b> : 350-359, 2012."},{"key":"12","unstructured":"12) Uckun, F.M., et al. : STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia\/lymphoma cells exposed to oxidative stress. Proc. Natl. Acad. Sci. USA<\/i> 107<\/b> : 2902-2907, 2010."},{"key":"13","unstructured":"13) Karaman, M.W., et al. : A quantative analysis of kinase inhibitor selectivity. Nat. Biotechnol<\/i>. 26<\/b> : 127-132, 2008."},{"key":"14"},{"key":"15"},{"key":"16","unstructured":"16) Ribbing, C., et al. : Mast cells generated from patients with atopic eczema have enhanced levels of granule mediators and an impaired Dectin-1 expression. Allergy<\/i> 66<\/b> : 110-119, 2011."},{"key":"17","unstructured":"17) Vautier, S., et al. : C-type lectin receptors and cytokines in fungal immunity. Cytokine<\/i> 58<\/b> : 89-99, 2012."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/4\/36_197\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:51:49Z","timestamp":1621486309000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/4\/36_197\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.36.197","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}